Authors: Perrillo, RP Wright, T Rakela, J Levy, G Schiff, E Gish, R Martin, P Dienstag, J Adams, P Dickson, R Anschuetz, G Bell, S Condreay, L Brown, N

Citation: Rp. Perrillo et al., A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis, HEPATOLOGY, 33(2), 2001, pp. 424-432

Authors: Hervas-Stubbs, S Lasarte, JJ Sarobe, P Vivas, I Condreay, L Cullen, JM Prieto, J Borras-Cuesta, F

Citation: S. Hervas-stubbs et al., T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine, J HEPATOL, 35(1), 2001, pp. 105-111

Authors: Bessesen, M Ives, D Condreay, L Lawrence, S Sherman, KE

Citation: M. Bessesen et al., Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine, CLIN INF D, 28(5), 1999, pp. 1032-1035

Authors: Dienstag, JL Schiff, ER Mitchell, M Casey, DE Gitlin, N Lissoos, T Gelb, LD Condreay, L Crowther, L Rubin, M Brown, N

Citation: Jl. Dienstag et al., Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy, HEPATOLOGY, 30(4), 1999, pp. 1082-1087

Authors: Tassopoulos, NC Volpes, R Pastore, G Heathcote, J Buti, M Goldin, RD Hawley, S Barber, J Condreay, L Gray, DF

Citation: Nc. Tassopoulos et al., Efficacy of lamivudine in patients with hepatitis B e antigen-negative hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B, HEPATOLOGY, 29(3), 1999, pp. 889-896